1. Adenovirus pneumonia should not be overlooked in immunocompetent youths and adults
- Author
-
Teng-Fei Yang, Bo Zhao, and Rui Zheng
- Subjects
medicine.medical_specialty ,Poor prognosis ,Original Paper ,Epidemiology ,business.industry ,Lymphocyte ,Symptomatic treatment ,Phlegm ,Bacterial pneumonia ,Leukocyte Counts ,medicine.disease ,respiratory tract diseases ,Pneumonia ,Infectious Diseases ,medicine.anatomical_structure ,Respiratory failure ,Internal medicine ,medicine ,Adenovirus ,pneumonia ,medicine.symptom ,business ,immunocompetent youths and adults - Abstract
Adenovirus pneumonia can occur in immunocompetent youths and adults. We conducted a retrospective analysis on five immunocompetent patients (aged ⩾14 years) with adenovirus pneumonia who visited our fever clinic between 1 February 2020 and 29 February 2020. The symptoms at clinical onset were fever, with cough and phlegm production either absent or appearing several days after disease onset. One patient with severe disease exhibited dyspnoea and a rapid development of respiratory failure. A subset of patients had concurrent gastrointestinal symptoms. The results of blood tests revealed normal leukocyte counts, decreased lymphocyte counts and increased C-reactive protein levels. The imaging findings resembled those of bacterial pneumonia, and pleural effusions were present in some cases. Most patients had a good prognosis with symptomatic treatment and supportive care. However, one patient with severe disease and a MuLBSTA score of >12 had a poor prognosis and ultimately died. Immunocompetent youths and adults may develop adenovirus pneumonia, and severe cases are at the risk of death. Since no effective treatments for adenovirus pneumonia are currently known, the early diagnosis and provision of symptomatic treatment and supportive care should be adopted to prevent the development and progression of severe disease.
- Published
- 2021